The efficacy of paclitaxel in a mammary adenocarcinoma mouse model was enhanced by the blockade of CSF-1R/CSF-1, with paclitaxel upregulating the production of CSF-1 [36]. Here, CSF1 is linked to breast adenocarcinoma.